Showing results (141-150 of 1,011) with videos related to
Sort By:
Pageof 102
Haemostasis|January 1, 1986
Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administrationJ Dawes, L Bara, E Billaud, et al.Thrombosis and Haemostasis|November 1, 1994
French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin timeJ Roussi, L Drouet, M Samama, et al.International Angiology : a Journal of the International Union of Angiology|October 1, 1989
Results of thrombolysis in the treatment of arterial ischemia of the limbs according to mode of administrationJ Marzelle, S Combe, F Gigou, et al.Thrombosis Research|October 15, 1992
A comparative study of recombinant hirudin and standard heparin in the Wessler modelL Bara, M F Bloch, M M SamamaThrombosis Research|June 1, 1990
The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasmaA V Bendetowicz, L Bara, M M SamamaJournal Des Maladies Vasculaires|January 6, 2010
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians]J Conard, M H Horellou, M M Samama, et al.La Ricerca in Clinica E in Laboratorio|October 1, 1989
Screening for inherited thrombotic disordersJ Conard, M H Horellou, M M SamamaThrombosis Research|September 3, 2014
Ex vivo reversal of the anticoagulant effects of edoxabanAbdel-Baset Halim, Meyer M Samama, Jeanne MendellActa Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M SamamaThrombosis Research|October 1, 1982
Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteinsC Fougnot, M Jozefowicz, L Bara, et al.Pageof 102